EGFR and cancer: Considering the cytotoxicity assays reported in the present work, the activity of both chimeric toxins on cancer cells correlates with the degree of EGFR expression confirming previous work of Bachran et al. that describes a clear correlation of EGFR expression to the sensitivity towards an EGFR-targeted RIP [34].